We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Andrew Haack
Andrew Haack
Products
PRODUCTS
AGC Biologics, Inc.
Michael Araneta
,
Teegan Dellibovi-Ragheb
,
Andrew Haack
,
Brian M. Janelsins
,
Charles Yuan-Chia Kuo
, and
Zhong Li
Price:
$117.00
View
GK Cosmetic Co., Ltd.
Andrew Haack
Price:
$117.00
View
Isorx Corp.
Andrew Haack
Price:
$117.00
View
C3 Co., Ltd.
Andrew Haack
Price:
$117.00
View
PicoBio Co., Ltd.
Andrew Haack
Price:
$117.00
View
NeoBiotech Global Corp.
Andrew Haack
Price:
$117.00
View
Olive Branch Natural Body Care, LLC
Andrew Haack
Price:
$117.00
View
lntersect ENT, Inc.
Andrew Haack
Price:
$117.00
View
Laclede, Inc.
Andrew Haack
and
Marcus F. Yambot
Price:
$117.00
View
Neutraderm, Inc.
Andrew Haack
Price:
$117.00
View
View All Products by Andrew Haack
Upcoming Events
04
Apr
Managing Data and Documentation for FDA Inspections and Remote Assessments
11
Apr
Integrating Regulatory Intelligence into Supplier Management
14
Apr
MAGI 2024: The Clinical Research Conference
25
Apr
A Masterclass on Effective 483 Responses
14
May
2024 Avoca Quality Consortium Summit
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
CDER Establishes New Quantitative Medicine Center of Excellence
Embracing, Expanding Sterilization Standards Endorsed in FDA Webinar
Six FDA Warning Letters Prompted by High Levels of Lidocaine in OTC Numbing Products
Comments on Benefit-Risk of Phthalates in Medical Devices Sought by EC
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More